secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001641172-25-021377
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 5.07
LLM model:  deepseek-v4-flash:cloud

Indaptus Therapeutics completes note conversion and obtains stockholder approval for private placement issuance
--------------------------------------------------------------------------------

- Raised gross proceeds of approximately $5.7 million in private placement of convertible notes and warrants, closed June 12 and June 30, 2025.
- On July 27, 2025, notes automatically converted into 545,598 common shares at $8.3024 per share; issued 1,384,722 warrants exercisable at same price.
- Also issued pre-funded warrants for 146,763 shares and placement agent warrants for 83,083 shares to Paulson Investment Company.
- At special meeting on July 25, 2025, shareholders approved issuance by 225,534 votes for (95.2%) and 225,161 votes for related-party issuance.
- Total votes represented 41.35% of outstanding shares, with quorum achieved; both proposals passed with overwhelming majority.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225021377/0001641172-25-021377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225021377/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer